H.R. 3196 · 109th Congress
Fair Access to Clinical Trials Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
42 cosponsors · 41 D, 1 I
31 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Fair Access to Clinical Trials Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to establish and operate a data bank of registry information on clinical trials for drugs, biological products, and devices.
What it does: CRS summary · Introduced in House · Jun 30, 2005
Fair Access to Clinical Trials Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to establish and operate a data bank of registry information on clinical trials for drugs, biological products, and devices. Requires the Secretary to collect, catalog, store, and disseminate such information.
Specifies information required for registration of clinical trials, including the purpose and results of the trial. Requires the responsible person to submit clinical trial information to the Secretary. Sets forth provisions regarding periodic updates of data bank information, compliance with requirements, and violations of this Act. Allows the Secretary to identify any false or misleading information in the data bank and include an accurate version of the information.
Requires the Secretary to: (1) disseminate data bank information through an Internet site and through other appropriate means; (2) establish procedures to allow voluntary submission of clinical trial information not required by this Act; and (3) enter into a contract with the Institute of Medicine to study the extent to which data submitted to the data bank has impacted the public health.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Fair Access to Clinical Trials Act
Latest action (Jul 29, 2005): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jun 30, 2005
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.